Johnson & Johnson »

Lyell Immunopharma shares owned by Johnson & Johnson

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Johnson & Johnson from 13F filings

Historical chart of Johnson & Johnson investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Johnson & Johnson

Quarter filed Position value Share count Share price at filing
2025-09-30 $669k 41k 16.24

More positions owned by Johnson & Johnson

Protagonist Therapeutics (PTGX)
Nanobiotix Sponsored Ads (NBTX)
Meiragtx Holdings (MGTX)
Rapport Therapeutics (RAPP)
CVRX (CVRX)
Legend Biotech Corporation Sponsored Ads (LEGN)
Contineum Therapeutics Cl A (CTNM)
Procept Biorobotics Corp (PRCT)
Xencor (XNCR)
Arrowhead Pharmaceuticals (ARWR)
Fate Therapeutics (FATE)
Neumora Therapeutics (NMRA)
Vor Biopharma
Rallybio Corp (RLYB)
Lyell Immunopharma (LYEL)

View all positions for Johnson & Johnson

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma